Medicine & Life Sciences
Neoplasms
100%
Prostatic Neoplasms
83%
Therapeutics
60%
Imatinib Mesylate
57%
Mutation
48%
Survival
48%
Gastrointestinal Stromal Tumors
41%
Acute Myeloid Leukemia
36%
Cell Transplantation
35%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
35%
Castration
35%
Protein-Tyrosine Kinases
32%
Drug Therapy
30%
Genes
29%
Breast Neoplasms
29%
Phosphotransferases
27%
Transplants
27%
Clinical Trials
27%
Recurrence
26%
Proteins
25%
Leukemia
23%
Progression-Free Survival
23%
Melanoma
23%
Neoplasm Metastasis
22%
T-Lymphocytes
22%
Early Detection of Cancer
22%
Bone Marrow
22%
Safety
21%
Colorectal Neoplasms
21%
Prostatectomy
21%
Biomarkers
20%
Allogeneic Cells
20%
Stem Cells
20%
Hematopoietic Stem Cells
19%
Androgens
19%
Pediatrics
19%
Confidence Intervals
18%
Prostate-Specific Antigen
18%
Macaca mulatta
18%
Mortality
18%
Pharmaceutical Preparations
18%
Lung Neoplasms
18%
Blood Platelets
18%
Liver
17%
Thrombosis
17%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
17%
Graft vs Host Disease
16%
DNA
16%
Databases
16%
Population
16%
MDV 3100
16%
Radiotherapy
16%
Community Health Centers
16%
Randomized Controlled Trials
15%
Adenocarcinoma
15%
Fanconi Anemia
15%
Genome
15%
Docetaxel
15%
Hemorrhage
15%
In Vitro Techniques
14%
Medicaid
14%
Growth
14%
Multiple Myeloma
14%
Prostate
14%
Health
14%
Primary Health Care
14%
Transplantation
14%
Child
14%
Placebos
14%
Hematopoietic Stem Cell Transplantation
14%
Cell Line
14%
Guidelines
13%
Brain
13%
Phenotype
13%
Gene Expression
13%
B-Cell Chronic Lymphocytic Leukemia
12%
Primates
12%
Biopsy
12%
Free Tissue Flaps
12%
Pancreatic Neoplasms
12%
Radiation
12%
Cancer Care Facilities
12%
Phosphorylation
12%
Electronic Health Records
12%
Infections
12%
Tissue Donors
12%
Veterans
11%
Immunotherapy
11%
Cytomegalovirus
11%
Quality of Life
11%
Hematologic Neoplasms
11%
Exercise
11%
Apoptosis
11%
Young Adult
11%
Tyrosine
11%
Epigenomics
11%
Myeloid Cells
10%
MicroRNAs
10%
Transcriptome
10%